Humoral Immunology Core Laboratory for AIDS Vaccine Research and Development

The National Institutes of Health is forecasting a contract for the establishment and operation of a Humoral Immunology Core Laboratory dedicated to supporting AIDS vaccine research and development. The laboratory will provide specialized immunological services focused on humoral immune responses, including antibody characterization, neutralization assays, and other critical analyses essential for evaluating vaccine candidates. The work is intended to facilitate the scientific advancement of HIV vaccine development through high-quality, standardized, and reproducible laboratory data generated by experts in the field. The contract is categorized under NAICS code 541714, indicating it involves research and development in the physical, engineering, and life sciences. The point of contact for program-related inquiries is Cesar Boggiano, while Robert Corno serves as the Contracting Officer. The opportunity was posted on May 25, 2026, and is currently in the forecast stage, meaning formal solicitation details are pending but stakeholders can anticipate a future bidding process. The place of performance and specific organizational set-aside status have not been specified, but the work is expected to be performed under the direct oversight of the NIH, with all outputs contributing to federally funded AIDS vaccine initiatives.